Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00967629 · ClinicalTrials.gov registry record · Phase 1
Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy
A Phase 1 study of Diabetic Nephropathy, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00967629: Completed Phase 1 study of Diabetic Nephropathy, sponsored by Icahn School of Medicine at Mount Sinai.
NCT00967629 is a Phase 1 study of Diabetic Nephropathy that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20 participants, below the 11,429-participant average among 9 other Diabetic Nephropathy trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00967629, a Phase 1 study of Diabetic Nephropathy, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether oral sevelamer carbonate binds advanced glycation end products (AGEs) in the gastrointestinal (GI) tract of patients with diabetic nephropathy leading to decrease body AGE load and therefore decreases the inflammation and oxidative stress in these patients.
Primary Outcome
To compare the effect of Sevelamer Carbonate versus calcium carbonate on serum AGE levels in patients with stage II-IV chronic kidney disease resulting from diabetic nephropathy from baseline to 2 months and to 4 months later.
Conditions Studied
Interventions
- DRUG Calcium Carbonate
- DRUG Sevelamer Carbonate
Study Locations (1)
New York
- Mount Sinai School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-02 |
| Phase | Phase 1 |
What the finished NCT00967629 record still lists
NCT00967629 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 11,429-participant average among 9 other Diabetic Nephropathy trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Diabetic Nephropathy appearing as the primary indexed condition, and to 2 interventions - of which Calcium Carbonate is the first listed.
NCT00967629 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00967629 about?
NCT00967629 is a clinical study titled "Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy". The purpose of this study is to determine whether oral sevelamer carbonate binds advanced glycation end products (AGEs) in the gastrointestinal (GI) tract of patients with diabetic nephropathy leading to decrease body AGE load and therefore decreases the inflammation and oxidative stress in these pa...
What is the current status of trial NCT00967629?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2009-06. Estimated completion is 2010-02.
What conditions does trial NCT00967629 study?
This clinical trial studies the following conditions: Diabetic Nephropathy.
What interventions are being tested in trial NCT00967629?
The interventions under investigation include: Calcium Carbonate (DRUG), Sevelamer Carbonate (DRUG).
Who is sponsoring clinical trial NCT00967629?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00967629 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Nephropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00967629's enrollment target sits among peer trials
20 9th of 9 higher than 1 of 9 other Diabetic Nephropathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Nephropathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
RECRUITING
-
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
COMPLETED · Phase 4
-
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
COMPLETED · Phase 2
-
Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.
COMPLETED · NA
-
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia